From September 27 to 30, 2024, The United Laboratories (Inner Mongolia) Co., Ltd. completed the pre-approval for tazobactam and ampicillin, as well as GMP compliance inspection for its newly added production facility. The company remains committed to improving its quality management system and institutionalizing GMP management to ensure drug quality at its source.